Medigus Ltd Adr Stock Price To Sales
MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Medigus Ltd ADR fundamentals help investors to digest information that contributes to Medigus' financial success or failures. It also enables traders to predict the movement of Medigus Stock. The fundamental analysis module provides a way to measure Medigus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medigus stock.
Medigus |
Medigus Ltd ADR Company Price To Sales Analysis
Medigus' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Medigus Price To Sales | 0.04 X |
Most of Medigus' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medigus Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Medigus Ltd ADR has a Price To Sales of 0.043 times. This is 99.8% lower than that of the Health Care Equipment & Supplies sector and 99.1% lower than that of the Health Care industry. The price to sales for all United States stocks is 99.62% higher than that of the company.
Medigus Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medigus' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medigus could also be used in its relative valuation, which is a method of valuing Medigus by comparing valuation metrics of similar companies.Medigus is currently under evaluation in price to sales category among its peers.
Medigus Fundamentals
Return On Equity | -0.31 | |||
Return On Asset | -0.0663 | |||
Profit Margin | (0.13) % | |||
Operating Margin | (0.09) % | |||
Current Valuation | 65.3 M | |||
Shares Outstanding | 1.89 M | |||
Shares Owned By Institutions | 0.29 % | |||
Number Of Shares Shorted | 4.18 K | |||
Price To Earning | 33.86 X | |||
Price To Book | 0.15 X | |||
Price To Sales | 0.04 X | |||
Revenue | 91.86 M | |||
Gross Profit | 4.8 M | |||
EBITDA | (11.99 M) | |||
Net Income | (10.1 M) | |||
Cash And Equivalents | 24.75 M | |||
Cash Per Share | 1.01 X | |||
Total Debt | 10.13 M | |||
Debt To Equity | 0.27 % | |||
Current Ratio | 1.38 X | |||
Book Value Per Share | 18.67 X | |||
Cash Flow From Operations | (5.66 M) | |||
Short Ratio | 0.32 X | |||
Earnings Per Share | (8.70) X | |||
Number Of Employees | 77 | |||
Beta | 1.37 | |||
Market Capitalization | 4.13 M | |||
Total Asset | 97.65 M | |||
Retained Earnings | (85.59 M) | |||
Working Capital | 14.63 M | |||
Current Asset | 46.34 M | |||
Current Liabilities | 7.23 M | |||
Net Asset | 97.65 M |
About Medigus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medigus Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medigus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medigus Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
CEOs Directory Screen CEOs from public companies around the world |